Safety Woes Make Country Of Origin Labeling "Foregone Conclusion" - Execs
This article was originally published in PharmAsia News
Executive Summary
Supplement firms should not underestimate the potential for consumers' concerns about the safety of raw materials imported from China to affect their sales, industry executives said Oct. 6 at the Council for Responsible Nutrition's annual conference
You may also be interested in...
Foreign Drug Inspections Would Be Funded By Registration Fees In Draft U.S. Bill
U.S. FDA inspections of overseas drug producers would be supported by annual registration fees under a legislative "discussion draft" being circulated by House Energy and Commerce Committee Chairman John Dingell, D-Mich.
Foreign Drug Inspections Would Be Funded By Registration Fees In Draft U.S. Bill
U.S. FDA inspections of overseas drug producers would be supported by annual registration fees under a legislative "discussion draft" being circulated by House Energy and Commerce Committee Chairman John Dingell, D-Mich.
Dingell Import Safety Bill Includes User Fees To Fund Foreign Inspections
Legislation introduced by House Energy and Commerce Committee members Sept. 20 to improve food and drug import safety would authorize user fees to be directed at hiring more FDA inspectors and other officials for import analysis in the U.S. and abroad